page_banner

News

  • Cancri statione contra: cancer universalis in...

    MINI PROBATIO stationem contra cancer: universalis cancer tantum figunt Chengchen Qian1, Xiaolong Zou2, Wei Li1,3, Yinshan Li4, Wenqiang Yu5 1Shanghai Epiprobe Biotechnology Co, Ltd, Shanghai (MMIIII)XXXIII, Sinis;2 Department of General Surgery, the First Affiliated Hospital of...
    Lege plus
  • Epiprobe Biotech primorum detectio productorum commendatur ab Perito Consenso in Detectione et Application Micio Tumoris DNA Methylation Markers (2024 edition)

    Epiprobe Biotech's early detection produc...

    Die 20 Aprilis 2024, Consensus Peritus de Detectione et Applicatione Cusci Tumoris DNA Methylation Markers (infra ad "Consensum" refertur, quod condensabatur ab Perito Committee Tumoris Markers Professio Comm...
    Lege plus
  • Epiprobe Biotech problema cancri ceruicis inhibitionis et curationis resiliunt: PCDHGB7 methylatio gene detectio adiuvat linamentum cancri cervicali non incursio

    Epiprobe Biotech problema colliculum cervicalis ...

    Cancer cervicus est cancer qui feminas diu flagellavit, cum plus quam 500,000 carcinomata cervicalia nova in toto anno et plus quam 300,000 mortes in anno.Praeventionis et curatio condicionis cancri cervicalis in Sinis trux est et incidentia ce...
    Lege plus
  • Methylation DNA Detection kits for endometrial Cancer: Intellectus Principii et Function

    Methylation DNA Detection Kits for Endometrial ...

    Cancer endometrialis praevalens malignitas gynecologica est, et prima eius detectio pendet curationi secundae.Methylation DNA detectionis kits ortae sunt sicut instrumentum spondeum primis diagnosi cancri endometrialis.Haec rhoncus ordinantur ad speciem deprehendendam...
    Lege plus
  • CCTV retis relatio: Epiprobe Biotech 100,000 casus cancri ceruicis protegendo investigationis cohortis studium publice immissi!

    CCTV retis fama: Epiprobe Biotech 100,000 c...

    Eliminare cancer ceruicis, Yi spectrum in actu.CCTV retis die VI Martii nuntium video de launched magna-scalarum publicarum saluti ne cancri cervicali in Shandong Province "Excutere cervical...
    Lege plus
  • Fudan University Research Team Targets Alius ...

    Die VI mensis Iulii anno MMXXII, turma investigationis a Dr. Yu Wenqiang ducebat ad Investigationem Instituti Fudani Universitatis Fudan Shanghai Cancer Centri foederatae Universitatis, in collaboratione cum biga apud Airforce Medical University Hospitalis Xijing, tertiam notavit ...
    Lege plus
  • Societas Epiprobe titulum vicit "Specia...

    Nuper Shanghai Commissio Municipalis Oeconomiae et Technologia Informationes album Shanghai parvi et mediocres conatibus enunciaverunt quae specializationem, elegantiam, proprietatem et novitatis (secundum massam secundam) anno 2022. Shanghai Epiprobe Biotechnologia Co., Ltd. innititur eius experti. .
    Lege plus
  • Ornamentum deprehensio Urothelial Cancri fuit recognitio ...

    Diluculo Maio 2023, TAGMe DNA Methylation Detection Ornamentum (qPCR) pro Urothelial Cancer independenter a Shanghai Epiprobe Biotechnologia Co., Ltd, adeptus "Breakper Fabricam Designationem" ab US FDA obtinuit.US FDA Breakthrough Devices Program tendit ad promovendum ...
    Lege plus
  • TAGMe DNA Methylation Detection Kits (qPCR) for...

    Solutio in cancro endometriali, cancrum tollendo in stadio laesionum precancium.Cancer endometrialis est unus e tribus carinis malignis maioribus in gynecologia.Cancer endometrialis est inter carros malignos maxime communes in systemate generationis feminae, ranki...
    Lege plus
  • Pan-cancer epiprobe biomarker secutus est...

    "Angelus Project" subtilitatem medicae paupertatis sublevandam adiuvat.Die 19 mensis Februarii anno 2023, Consilium Centrale Sinensium Consultationis Politicae Conferentiae (CPPCC) et Siemens coniunctim in Gansu Provinciae Custos Angelum Projectum emiserunt, instrumentis provectis donando...
    Lege plus
  • Epiprobe feliciter ISO13485 Q...

    Producta certa ac stabilis sunt vita societatis.Cum instauratio eius fere ante annos V, Epiprobe semper qualitatem primam posuit, utentes cum summus qualitas et certa cancer productos primos protegendo.Die 9 mensis Maii anno 2022, post accuratam recognitionem ab experientia ...
    Lege plus
  • Baidu Salus et Epiprobe cooperative promovent exsecutionem primi pan-cancri protegendo

    Baidu Salus et Epiprobe cooperatively.

    30 Oct. 2022, Baidu Salus Internet Hospitalis (retulit "Baidu Health") et Shanghai Epiprobe Biotechnologia Co, Ltd. (relatum "Epiprobe") opportuna denuntiavit cooperationem ut pan-cancer primos protegendo in clinicis et communibus sanitatis canales duri...
    Lege plus
12Next >>> Page 1 / 2